A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme

NCT05600491 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Anaplastic Oligoastrocytoma
Glioblastoma

Interventions

DRUG: Temozolomide

Sponsor

Sun Yat-sen University